FBXW7 and colorectal carcinoma: Our experiments demonstrated that FBW7 R465C significantly attenuates irinotecan/SN38 efficacy in both cellular and animal models; restoration of FBW7 R465C in FBW7‐knockout CRC cells fails to rescue SN38 sensitivity.